CSL announced the exit of Paul McKenzie as chief executive. Senior executive Gordon Naylor appointed interim CEO. Shares of Australian biotech firm CSL plunged to an 8-year low Wednesday after it ...

The new M4 CSL is a 543-horsepower track junkie weighing in at 3,640 pounds, after losing a rather heavy passenger’s worth of weight through clever engineering and material upgrades. For those of you ...

CSL Consulting LLC (“CSL Consulting”) today announced a major expansion into the Southeastern United States through its acquisition of Brownstone Construction Group LLC (“Brownstone” or the “Company”) ...

Australian biopharma CSL has a rich history. The company, which was originally called Commonwealth Serum Laboratories, was started by the government during World War I as a means to get critical ...

CSL is laying off up to 15% of its workforce as the Australian pharma looks to cut R&D costs and spin out its vaccine subsidiary in a wide-ranging restructure. The Melbourne-headquartered company will ...

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Vanguard Group’s decision to lift its stake in CSL ...

The site will support CSL's growing R&D portfolio, accelerating the development of next-generation mRNA technology for vaccines "CSL's growing R&D presence in Waltham is the latest example of our ...

BMW M is celebrating its 50th anniversary this year and we can’t think of a better way to mark the occasion than the announcement of a new M4 CSL (Competition Sport Lightweight). While the M3 ...

We are closer to the demise of legally buying a new ICE vehicle in California (13 years) than we are to the initial introduction of the Tesla Roadster (15 years). Despite this, the internal combustion ...